Fate Therapeutics, Inc. · NASDAQ:FATE
Schonfeld Strategic Advisors LLC's stake in Fate Therapeutics, Inc. fell to 0.82% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Schonfeld Strategic Advisors LLC's stake in Fate Therapeutics, Inc. fell to 0.82%, 937,521 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 0.82%
- Shares
- 937,521
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 0.82% | 937,521 |
Source
Related
- Fate Therapeutics, Inc.
- Schonfeld Strategic Advisors LLC
- Fate Therapeutics, Inc. shareholders
- Schedule 13G · Schonfeld Strategic Advisors LLC · May 15, 2025
- Form 4 · Tahl Cindy · Aug 5, 2026
- Form 4 · Valamehr Bahram · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 8, 2026
- Form 4 · Tahl Cindy · May 21, 2026
- Form 4 · Valamehr Bahram · May 21, 2026